Device
Focused extracorporeal shockwave therapy
Focused extracorporeal shockwave therapy is a medical device with 3 clinical trials. Currently 3 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
3(100%)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Recruiting3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
recruiting3100%
Recent Activity
3 active trials
Showing 3 of 3
recruitingphase_1
Shockwave for Elbow and Wrist Spasticity in People With Spinal Cord Injury
NCT07501429
recruitingnot_applicable
Focused Extracorporeal Shockwave Therapy for Knee Arthritis
NCT05596591
recruitingnot_applicable
Effects of Focal Extracorporeal Shock Wave Therapy in the Treatment of Temporomandibular Disorders of Muscular Origin
NCT05907239
Clinical Trials (3)
Showing 3 of 3 trials
NCT07501429Phase 1
Shockwave for Elbow and Wrist Spasticity in People With Spinal Cord Injury
NCT05596591Not Applicable
Focused Extracorporeal Shockwave Therapy for Knee Arthritis
NCT05907239Not Applicable
Effects of Focal Extracorporeal Shock Wave Therapy in the Treatment of Temporomandibular Disorders of Muscular Origin
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3